• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[超分割照射在不可手术肺癌放疗中的疗效]

[Effectiveness of super-fractionated irradiation in the radiotherapy of inoperable lung cancer].

作者信息

Leskov V P, Larin B S, Mardynskiĭ Iu S

出版信息

Med Radiol (Mosk). 1986 Jun;31(6):7-11.

PMID:3014259
Abstract

The paper is concerned with the results of gamma-beam therapy of 120 patients with inoperable lung cancer using the fractionation of a common daily dose of 2-2.2 Gy into 2 equal fractions as a variant of super-fractionated irradiation used in clinical practice. The direct and short-term therapeutic results were improved: a complete tumor regression rate determined by x-ray was 26.7%, a 2-year survival rate 19.2%. In the group of patients who were irradiated by the commonly used methods, the same values were lower. Improved tolerance of therapy with fractionation of a common daily dose was noted.

摘要

本文关注的是120例无法手术的肺癌患者采用伽马射线治疗的结果,即将常规每日剂量2 - 2.2 Gy分为2个相等部分作为临床实践中使用的超分割照射变体。直接和短期治疗效果得到改善:经X线测定的肿瘤完全消退率为26.7%,2年生存率为19.2%。在采用常用方法照射的患者组中,这些数值较低。注意到采用常规每日剂量分割后治疗耐受性有所改善。

相似文献

1
[Effectiveness of super-fractionated irradiation in the radiotherapy of inoperable lung cancer].[超分割照射在不可手术肺癌放疗中的疗效]
Med Radiol (Mosk). 1986 Jun;31(6):7-11.
2
[Dose multifractionation in radiotherapy of lung cancer of different histological types].[不同组织学类型肺癌放疗中的多分次剂量]
Med Radiol (Mosk). 1987 Jul;32(7):30-3.
3
[Effectiveness of the radiation therapy of lung cancer with conventional and median dosage fractionation].[常规与中等剂量分割肺癌放射治疗的疗效]
Med Radiol (Mosk). 1985 Aug;30(8):22-4.
4
Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.放射治疗肿瘤学组(RTOG)9311的毒性反应和结果:一项针对无法手术的非小细胞肺癌患者采用三维适形放疗的I-II期剂量递增研究。
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):318-28. doi: 10.1016/j.ijrobp.2004.06.260.
5
Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.血清标志物能否用于预测肺癌患者的急性和晚期毒性?RTOG 91-03分析。
Am J Clin Oncol. 2007 Aug;30(4):368-76. doi: 10.1097/01.coc.0000260950.44761.74.
6
Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.一项使用三维适形放疗的非小细胞肺癌I/II期剂量递增试验的最终结果。
Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):126-34. doi: 10.1016/j.ijrobp.2006.04.034.
7
[Fractionated postoperative irradiation in combined therapy of lung cancer].
Med Radiol (Mosk). 1984 Mar;29(3):10-3.
8
[Remissions and acute toxicity during accelerated fractionated irradiation of non-small-cell bronchial carcinoma].[非小细胞支气管癌加速分割照射期间的缓解情况及急性毒性]
Strahlenther Onkol. 1986 May;162(5):300-7.
9
[Results of megavoltage radiotherapy of advanced forms of lung cancer under conditions of static fractionated irradiation].[在静态分次照射条件下晚期肺癌的兆伏级放射治疗结果]
Med Radiol (Mosk). 1983 Jan;28(1):7-13.
10
[Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].[上沟非小细胞肺癌的手术治疗:术前与术后联合放疗方案的结果]
Zentralbl Chir. 2004 Aug;129(4):270-5. doi: 10.1055/s-2004-822831.